Vaxcyte, Inc. Annual Operating Income (Loss) in USD from 2018 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vaxcyte, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
- Vaxcyte, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$162M, a 17.5% increase year-over-year.
- Vaxcyte, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$570M, a 21.7% decline year-over-year.
- Vaxcyte, Inc. annual Operating Income (Loss) for 2024 was -$570M, a 21.7% decline from 2023.
- Vaxcyte, Inc. annual Operating Income (Loss) for 2023 was -$468M, a 102% decline from 2022.
- Vaxcyte, Inc. annual Operating Income (Loss) for 2022 was -$232M, a 124% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)